Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical...
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the NHS in the...
Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal worth as much as $5.3...
Sanofi has revealed that Dupixent has been awarded marketing approval by the European Commission as an add-on maintenance treatment for severe...
Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell...
Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million.
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary endpoints in a randomised, double...
The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (...
Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine myths had “...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches